Unknown

Dataset Information

0

YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis via aberrant glycolysis associated with EGFR/PKM2/HIF-1α pathway.


ABSTRACT: Objectives: Dimeric pyruvate kinase (PK) M2 (PKM2) plays an important role in promoting the accumulation of hypoxia-inducible factor (HIF)-1α, mediating aberrant glycolysis and inducing fibrosis in diabetic kidney disease (DKD). The aim of this work was to dissect a novel regulatory mechanism of Yin and Yang 1 (YY1) on lncRNA-ARAP1-AS2/ARAP1 to regulate EGFR/PKM2/HIF-1α pathway and glycolysis in DKD. Materials and methods: We used adeno-associated virus (AAV)-ARAP1 shRNA to knocked down ARAP1 in diabetic mice and overexpressed or knocked down YY1, ARAP1-AS2 and ARAP1 expression in human glomerular mesangial cells. Gene levels were assessed by Western blotting, RT-qPCR, immunofluorescence staining and immunohistochemistry. Molecular interactions were determined by RNA pull-down, co-immunoprecipitation, ubiquitination assay and dual-luciferase reporter analysis. Results: YY1, ARAP1-AS2, ARAP1, HIF-1α, glycolysis and fibrosis genes expressions were upregulated and ARAP1 knockdown could inhibit dimeric PKM2 expression and partly restore tetrameric PKM2 formation, while downregulate HIF-1α accumulation and aberrant glycolysis and fibrosis in in-vivo and in-vitro DKD models. ARAP1 knockdown attenuates renal injury and renal dysfunction in diabetic mice. ARAP1 maintains EGFR overactivation in-vivo and in-vitro DKD models. Mechanistically, YY1 transcriptionally upregulates ARAP1-AS2 and indirectly regulates ARAP1 and subsequently promotes EGFR activation, HIF-1α accumulation and aberrant glycolysis and fibrosis. Conclusion: Our results first highlight the role of the novel regulatory mechanism of YY1 on ARAP1-AS2 and ARAP1 in promoting aberrant glycolysis and fibrosis by EGFR/PKM2/HIF-1α pathway in DKD and provide potential therapeutic strategies for DKD treatments.

SUBMITTER: Li X 

PROVIDER: S-EPMC9974832 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature

altmetric image

Publications

YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis <i>via</i> aberrant glycolysis associated with EGFR/PKM2/HIF-1α pathway.

Li Xin X   Ma Tian-Kui TK   Wang Min M   Zhang Xiao-Dan XD   Liu Tian-Yan TY   Liu Yue Y   Huang Zhao-Hui ZH   Zhu Yong-Hong YH   Zhang Shuang S   Yin Li L   Xu Yan-Yan YY   Ding Hong H   Liu Cong C   Shi Hang H   Fan Qiu-Ling QL  

Frontiers in pharmacology 20230215


<b>Objectives:</b> Dimeric pyruvate kinase (PK) M2 (PKM2) plays an important role in promoting the accumulation of hypoxia-inducible factor (HIF)-1α, mediating aberrant glycolysis and inducing fibrosis in diabetic kidney disease (DKD). The aim of this work was to dissect a novel regulatory mechanism of Yin and Yang 1 (YY1) on lncRNA-ARAP1-AS2/ARAP1 to regulate EGFR/PKM2/HIF-1α pathway and glycolysis in DKD. <b>Materials and methods:</b> We used adeno-associated virus (AAV)-ARAP1 shRNA to knocked  ...[more]

Similar Datasets

| S-EPMC11875784 | biostudies-literature
| S-EPMC8089020 | biostudies-literature
| S-EPMC8286140 | biostudies-literature
| S-EPMC11677236 | biostudies-literature
| S-EPMC6993409 | biostudies-literature
| S-EPMC7701572 | biostudies-literature
| S-EPMC6138389 | biostudies-literature
| S-EPMC8254807 | biostudies-literature
| S-EPMC8741836 | biostudies-literature
| S-EPMC5481455 | biostudies-literature